While children receiving chemotherapy routinely undergo hearing tests, adults don’t, and a new study by UC San Francisco (UCSF) reports for the first time that significant hearing issues often occur among adult survivors of the most common forms of cancer. The researchers found that more than half the survivors in their study who had been treated with chemotherapy experienced significant hearing problems.
Examining data from 33,552 people included in a national health survey from 2010-2013, South Korean researchers found that the risk of age-related hearing loss nearly doubles in diabetic patients who smoke cigarettes.
The data show hearing improvements in adults with acquired sensorineural hearing loss (SNHL) and the “first known linkage of pharmacokinetics and pharmacodynamics for a potential hearing restoration therapy,” according to Frequency.
According to the CRL, after recent completion of a pre-approval inspection of the manufacturing facility of our drug product manufacturer, the FDA identified deficiencies resulting in a Form 483, which is a list of conditions or practices that are required to be resolved prior to the approval of PEDMARK.
Read More
Findings show that survivors with severe hearing loss are at a significantly increased risk for neurocognitive deficits, independent of what type of therapy they receive.
Read More
In an article on “Forbes,” professor and journalist Bruce Y. Lee reviews the evidence currently available regarding the link between COVID-19 and hearing loss.
Read More
PEDMARK is said to be an investigational drug for the prevention of ototoxicity induced by cisplatin chemotherapy in patients one month to <18 years of age with localized, non-metastatic, solid tumors.
Read More
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN), a clinical-stage biotech company which specializes...
Read More
Researchers involved with a qualitative study published in Cancer concluded that clinicians play...
Read More
For those companies or individuals who have a concern about hearing damage that may have been...
Read More
The proteins, described in a report published June 12 in “eLife,” may hold a key to future therapies to restore hearing in people with irreversible deafness. An article summarizing the research was published on the Johns Hopkins Medicine website.
Read More
SENS-401 is under development in the treatment of Sudden Sensorineural Hearing Loss (or SSNHL).
Read More
SENS-401 is under development in the treatment of Sudden Sensorineural Hearing Loss (or SSNHL).
Read More
SENS-401 is under development in the treatment of Sudden Sensorineural Hearing Loss (or SSNHL).
Read More
The book describes major advances in our understanding of the pathogenic processes underlying various forms of hearing loss and the emergence of treatments for deafness.
Read More
In Phase 1, CILcare was reportedly able to correlate electrophysiology, manganese-enhanced magnetic resonance imaging (MEMRI), and behavioral assessments that define a preclinical model for detecting tinnitus. In Phase 2, CILcare will adapt the preclinical model to humans.
Read More
Since 2016, the Ida Institute Research Committee has awarded research grants to projects that investigate the outcomes of using Ida Institute methods and tools and develop evidence to show the effect of person-centered hearing care.
Read More
The researchers were able recreate the development of human hair cells via an in-vitro method in the laboratory. As a result, future research may allow pharmacological treatments to be tested on human cells.
Read More